|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.545 EUR | +3.00% |
|
-11.21% | -61.38% |
Sequana Medical NV reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 0.464446 million compared to EUR 0.0225 million a year ago. Net loss was EUR 14.86 million compared to EUR 11.89 million a year ago.
Basic loss per share from continuing operations was EUR 0.68 compared to EUR 0.66 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -61.38% | 49.16M | |
| +64.23% | 62.59B | |
| -2.31% | 41.18B | |
| +44.36% | 40.29B | |
| -8.29% | 27.9B | |
| +11.97% | 26.21B | |
| -21.16% | 19.09B | |
| +7.54% | 13.08B | |
| +27.17% | 12.05B | |
| +25.72% | 12.26B |
SEQUANA MEDICAL N.V. 
